Table 3.
Characteristic | Control strategy (n = 292) | Intervention strategy (n = 489) | P value |
---|---|---|---|
Genetic counselor consulted | 41 (14%) | 67 (14%) | 0.89h |
Diagnosis after genetic testing | |||
Yes | 35 (12%) | 46 (9.4%) | 0.25h |
Familial colorectal cancera | 26 | 32 | |
Lynch syndrome | 3 | 2 | |
Lynch like syndrome | 1 | 0 | |
Polyposis syndrome | 5e | 3f | |
Unknown yet, but definite diagnosis | 0 | 9g | |
No | 6 (2.1%) | 17 (3.5%) | |
Syndrome ruled out | 5 | 16 | |
Wrong referral indication | 1 | 1 | |
Unknown yetb | 0 | 4 (0.8%) | |
Colonoscopy screening/surveillance recommendation | |||
Yes | 35 (12%) | 46 (9.4%) | 0.25h |
For patient | 3 | 3 | |
For patient and relativesc | 14 | 18 | |
For relativesc | 18 | 16 | |
For patient and possibly relativesd | 0 | 9 |
aDefined as a familial risk of CRC, without a known genetic cause, for which screening or surveillance recommendations are given
bGenetic testing ongoing, unknown if a genetic or familial diagnosis will be made
cColonoscopy screening and/or surveillance recommendations for relatives included: Colonoscopy surveillance 1×/5 year from the age of 37, 38, 40 or 45: n = 51, Colonoscopy screening at the age of 45, 50, 55 or 65: n = 14, Colonoscopy surveillance 1×/2 year from the age of 25: n = 1
dGenetic testing ongoing that will certainly result in a genetic or familial diagnosis
eIncluding three patients with serrated polyposis syndrome, two with polyposis of unknown origin
fIncluding one patient with polyposis of unknown origin, one with MUTYH associated polyposis and one with serrated polyposis syndrome
gGenetic test result unknown yet (either Lynch syndrome or FCC in eight and genetic or non-genetic polyposis in one)
h2-Sided chi square test